Fospropofol
- Generic Name
- Fospropofol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C13H21O5P
- CAS Number
- 258516-89-1
- Unique Ingredient Identifier
- LZ257RZP7K
- Background
Fospropofol is a water soluble prodrug and is converted to propofol in the liver. Fospropofol is a short acting hypnotic/sedative/anesthetic agent. Unlike propofol, does not cause injection-site pain as it is unable to activate TRPA1. FDA approved in December 2008.
...
- Indication
For monitored anaesthesia care sedation in patients undergoing diagnostic procedures like bronchoscopy and colonscopy or minor surgical procedures like arthroscopy and bunionectomy.
- Associated Conditions
- -
- Associated Therapies
- Monitored anesthesia care sedation
Parkinson's drug comes to market with help of renowned University of Kansas
New drug therapy Vyalev, developed by AbbVie with input from KU's Valentino Stella, aims to improve Parkinson’s treatment with a wearable pump delivering consistent L-dopa/carbidopa therapy. FDA approved in 2024, Vyalev showed superior motor symptom control in clinical trials. Stella, with a history of inventing FDA-approved drugs, highlights the impact of his work on patients' lives.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath